PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA

被引:0
|
作者
Rauf, Yasmeen [1 ]
Hufsey, Rachel [2 ]
Robinson, Kathy [2 ]
Suh, John [2 ]
Chao, Samuel [2 ]
Murphy, Erin [2 ]
Yu, Jennifer [2 ]
Peereboom, David [2 ]
Ahluwalia, Manmeet [3 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CTNI-42
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [1] PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Yu, Jennifer
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 51 - 51
  • [2] Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John H.
    Chao, Samuel T.
    Murphy, Erin Sennett
    Yu, Jennifer S.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
  • [4] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Rauf, Yasmeen
    Peereboom, David
    Fallah, Jaleh
    Schilero, Cathy
    Lackner, Pamela
    Stevens, Glen
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [5] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [6] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew
    Wong, Eric T.
    Doherty, Lisa
    LaFrankie, Debra
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Lassman, Andrew B.
    Schiff, David
    Batchelor, Tracy
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [7] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma
    Drappatz, J.
    Norden, A. D.
    Wong, E. T.
    Lassman, A. B.
    Doherty, L.
    LaFrankie, D.
    Gerard, M.
    Phan, P.
    Schiff, D.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [9] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [10] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19